John E. Cyr
Bayer (Germany)(DE)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Crystallization and Solubility Studies, Peptidase Inhibition and Analysis, X-ray Diffraction in Crystallography, Electrochemical Analysis and Applications
Most-Cited Works
- → Synthesis, 18F-Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks(2008)123 cited
- → TcO(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction(1994)120 cited
- → Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine(2009)113 cited
- → Silicon‐Based Building Blocks for One‐Step 18F‐Radiolabeling of Peptides for PET Imaging(2008)109 cited
- → Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate(2005)105 cited
- → The Oxidation of Phenol by Ferrate(VI) Andferrate(V). A Pulse Radiolysis and Stopped-Flow Study(1995)99 cited
- → Somatostatin Receptor-Binding Peptides Suitable for Tumor Radiotherapy with Re-188 or Re-186. Chemistry and Initial Biological Studies(2007)45 cited
- → Imaging Ischemic Tissue at Risk of Infarction during Stroke(1993)40 cited
- → GLUT 5 Is Not Over-Expressed in Breast Cancer Cells and Patient Breast Cancer Tissues(2011)39 cited
- → The reduction of ferrate(VI) to ferrate(V) by ascorbate(1991)38 cited